quadraScope Venture Fund — 2026 Investments
1 investments dated 2026 · listed companies and verified rows first · show all
Immunis Biomedicalimmunisbiomedical.cominMay 2026
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)Hans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSRemiges Ventures, Inc.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.